Value analysis committee: how hospitals approve new products, and how suppliers get through
What a hospital value analysis committee is, who sits on it, what evidence it asks for and why a clinician has to submit your product, drawn from published hospital policies.
Short answer
A value analysis committee is the group that decides whether a hospital adopts a new medical product. It reviews clinical evidence, cost and outcomes, and its members usually include supply chain, physicians, nurses and finance. Suppliers usually cannot submit a product themselves: a clinician sponsor files the request, and the supplier provides the evidence.
Most guides to the value analysis committee are written for the people who run one. This one is for suppliers. It is built from published hospital policies, so the rules, forms and timelines below come from real hospitals, not opinion.
What a value analysis committee is in a hospital
A hospital value analysis committee, often shortened to VAC, decides which medical products the hospital adopts and which ones it standardizes on. Corewell Health describes its value analysis program as a systematic, objective, evidence-based process to evaluate current and developing technologies, with the aim of managing expense while keeping safety and quality.1
In a peer-reviewed column, a co-chair of the orthopaedic value analysis committee at Northwestern Medicine, an 11-hospital system, describes the main job as adopting and standardizing products, and notes that committees have grown in importance as payment shifts from fee-for-service toward value-based care.2
The profession has its own bodies. The Association of Healthcare Value Analysis Professionals (AHVAP) runs the CVAHP certification for value analysts, and AHRMM's Cost, Quality and Outcomes movement treats the three as one equation.34
Who sits on a hospital value analysis committee
Membership changes by hospital and by product category, but most committees draw from the same groups.
- Value analysis and supply chain. The value analysis director or analysts run the process, and supply chain brings pricing, contracts and cost comparisons.
- Physicians. Usually a physician lead for the specialty, and the surgeons or proceduralists who would use the product.
- Nursing. Nurse leaders from the units where the product is used.
- Finance. Budget and reimbursement impact.
- Specialists as needed. Quality, infection prevention, clinical engineering and IT join when the product touches their area.
Health systems often split the work. CentraCare runs ten category committees, such as surgical, imaging, laboratory and advanced wound care, under a value analysis steering committee.5 In a 2024 survey of value analysis leaders by GHX and AHVAP (co-funded by GHX, a supply chain software vendor), about 58% of respondents worked in IDNs.6
What a value analysis committee looks at: cost, quality and outcomes
A committee asks whether a new product delivers more value than what the hospital uses today. The Northwestern Medicine co-chair sums it up as quality divided by cost.2
In practice that means four questions:
- Is it safe and does it work? Clinical evidence, ideally independent of the manufacturer.
- What does it cost, all in? Price per unit, per procedure and per year, against the current product.
- Will we be paid for it? Reimbursement, and the effect on the hospital's margin.
- What else changes? Training, workflow, storage, IT connections and whether it replaces a product or adds one.
Legacy Health's policy, for example, lists established reimbursement and a neutral or positive margin among its approval criteria.7
How a new product request reaches the value analysis committee, step by step
The steps differ by hospital, but most published policies follow the same order. The University of Arkansas for Medical Sciences (UAMS) is a clear example.8
A clinician sponsors the request
At UAMS, since May 13, 2024, a UAMS clinician starts every new product or trial request with a 10-question short form.
The supplier completes its part
The vendor rep then fills in a longer form with product, evidence and pricing details.
Value analysis adds the numbers
The value analysis team projects the financial impact for the hospital.
The sponsor presents
The clinician sponsor presents the request at the monthly Value Analysis Committee meeting.
The committee votes
The committee approves, denies or asks for a trial or more information.
Why a sales rep cannot submit a value analysis request without a clinician sponsor
The most important rule in hospital value analysis is that the request has to come from inside the hospital.
At the University of Utah Health, the physician champion must submit requests for surgical areas, and other areas need a clinical sponsor.9 Covenant HealthCare in Michigan goes further: its policy says vendor reps may not complete or submit requests.10
So the first job is not the committee. It is finding a physician or nurse leader who has the problem your product solves and will put their name on the request. Without a sponsor, the best evidence packet never reaches the agenda.
Tip
Find two sponsors, not one
A request with a physician sponsor and a nurse leader who supports it carries more weight, and it survives if one of them changes roles before the vote.
What evidence a value analysis committee asks suppliers for
Hospitals publish what they want to see. Put together, these policies describe the packet a supplier should have ready before a sponsor files.
The value analysis packet
0 of 7 checked
HonorHealth asks for a request form, clinical or financial evidence and the FDA approval letter, and Legacy Health sends products that touch patient data or interfaces to its Information Services team for review.117
How long hospital value analysis takes, from request to vote
Expect weeks to months. Most committees meet monthly, so a request that misses one meeting waits for the next.
Covenant HealthCare asks for at least 21 business days before review. It sends new technology or products with high financial impact, defined as $500 or more added per procedure or $25,000 or more added per year, to a monthly advisory council, and it scores requests on a 0 to 27 scale.10
A denial can be expensive. Covenant will not review a denied request again for one year unless new evidence appears.10 Get the packet right the first time.
Value analysis in a health system: system committees vs hospital committees
In a health system, the committee that decides may sit above the hospital you are calling. Northwestern Medicine runs a system-level orthopaedic committee across its 11 hospitals, and CentraCare runs its category committees for the whole system.25
That changes the work. You need a sponsor at a hospital that uses the product, and you need to know which system committee reviews your category and when it meets. A product approved at the system level can open every hospital in the system at once.
See how to find out who owns a hospital to map which hospitals sit under which system.
Which purchases go to value analysis and which go to IT, capital or P&T committees
Value analysis is not the only gate. Large hospitals send different purchases to different committees, and a product can need more than one.
| What is being bought | Usual committee | What it checks |
|---|---|---|
| Medical and surgical supplies, implants, devices | Value analysis committee | Evidence, cost, standardization |
| New high-cost technology | Technology assessment committee or advisory council | Clinical value, strategic fit, financial impact |
| Drugs | Pharmacy and therapeutics (P&T) committee | Formulary fit, safety, cost |
| Software and connected systems | IT governance and security review | Data handling, interfaces, support |
| Large equipment | Capital committee, with clinical engineering | Budget, capital priority, maintenance |
CentraCare, for example, runs a Medical Technology Assessment Committee and a P&T committee alongside its value analysis committees.5 For how capital and IT purchases move, see how hospitals buy, by purchase type.
How value analysis approval and GPO contracts fit together
A GPO contract and a value analysis approval answer different questions. The GPO contract sets the price and terms a member hospital can buy at. Value analysis decides whether the hospital's clinicians may use the product at all.
Being on contract helps, because supply chain does not have to negotiate a new agreement. But it does not get a product past the committee. Read how GPO contracts work for hospital suppliers for the other half.
Value analysis rules that can get a supplier blocked
Hospitals enforce value analysis with conduct rules for reps, and breaking one can cost you the account.
- No samples or in-services without approval. HonorHealth does not let reps leave samples or run in-services without authorization.11
- No purchase order, no payment. HonorHealth will not issue a purchase order without value analysis approval, and CentraCare does not pay for products introduced without approval.115
- No going around the process. Reps who push a product straight to a clinician or a unit can be barred from the facility.
Watch out
Read the supplier policy before the first visit
Most hospitals post their supplier rules and value analysis policy on a supplier or vendor page. Read it before you contact a clinician, and follow the credentialing steps it lists.
How to find the value analysis team at a target hospital
Before you look for a sponsor, map the people who run the process at the hospital and at its parent system.
- Check the supplier page. Many hospitals publish their value analysis process and contact on it.
- Find the parent system. If the hospital belongs to a health system, the committee for your category may sit at the system level.
- Find the value analysis and supply chain leaders. The director of value analysis, the analysts and the VP of supply chain run the process.
- Find possible sponsors. The department chair, the physician lead for the specialty and the nurse leaders on the units that would use your product.
- Check how to reach them. Get a working email and direct dial, and look for a colleague or customer who knows them.
Dmand AI maps 1.6K+ health systems and IDNs down to 997K+ sites of care, with 11M+ healthcare executives and 7.4M+ HCPs attached to the site where they work, so you can see the supply chain leaders and the clinicians at the same hospital in one view.
Find the value analysis and supply chain leaders at your target hospital
Open any hospital or health system, see the supply chain, value analysis and clinical leaders at each site, and get their contact details. 30 days free, self-serve, no credit card.
30 days free, self-serve, no credit card
Sources
- Value Analysis ProgramCorewell Health
- Value-based healthcare: controlling costs through a value analysis committeeKalainov DM, Clinical Orthopaedics and Related Research, 2024
- CommitteesAssociation of Healthcare Value Analysis Professionals
- What is CQO?AHRMM, American Hospital Association
- Value analysis for vendorsCentraCare
- Healthcare Value Analysis Today and TomorrowAHVAP and GHX, 2024
- New Supply and Equipment Procurement PolicyLegacy Health
- Value Analysis Product RequestUAMS Supply Chain
- New productsUniversity of Utah Health Supply Chain
- Clinical Quality Product Value Analysis PolicyCovenant HealthCare
- Introduction of medical and surgical productsHonorHealth

Written by
Supreet Gupta
Co-founder and Chief Product Officer, Dmand AI
Supreet is the co-founder and Chief Product Officer of Dmand AI. He leads the product and the healthcare data behind it, and writes Selling Into Healthcare, a newsletter on how US health systems buy.